| Hazard Information | Back Directory | [Uses]
CT1113 is a potent USP28 and USP25 inhibitor. CT1113 decreases the MYC level in vivo，exhibits anti-tumor activity in mouse pancreatic cancer CDX model[1]. | [References]
[1] Peng J, et al. Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity. Signal Transduct Target Ther. 2022 Dec 8;7(1):393. DOI:10.1038/s41392-022-01209-2 |
|
| Company Name: |
ChemOrigin Pharm
|
| Tel: |
15026428026 19002516454 |
| Website: |
www.chemorigin.com |
|